These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9413091)

  • 61. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
    Letvin NL; Miller MD; Shen L; Chen ZW; Yasutomi Y
    Semin Immunol; 1993 Jun; 5(3):215-23. PubMed ID: 8394161
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.
    Panicali DL; Mazzara G; Sullivan JL; Hesselton R; Shen L; Letvin N; Daniel M; Desrosiers R; Stott EJ
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1449. PubMed ID: 1466979
    [No Abstract]   [Full Text] [Related]  

  • 64. Ultraviolet-irradiated vaccinia virus recombinants, exposing HIV-envelope on their outer membrane, induce antibodies against this antigen in rabbits.
    Loewinger M; Katz E
    Viral Immunol; 2002; 15(3):473-9. PubMed ID: 12479396
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prospects for an AIDS vaccine.
    Girard M
    Cancer Detect Prev; 1990; 14(3):411-3. PubMed ID: 2117487
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.
    Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1501-5. PubMed ID: 1466990
    [No Abstract]   [Full Text] [Related]  

  • 67. Characterization of group specific antibodies in primates: studies with SIV envelope in macaques.
    Haigwood NL; Misher L; Chin SM; Blair M; Planelles V; Scandella CJ; Steimer KS; Gardner MB; Yilma T; Hirsch VM
    J Med Primatol; 1992; 21(2-3):82-90. PubMed ID: 1433271
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bovine alpha-2-HS-glycoprotein functions as a booster antigen for efficiently stimulating humoral immune responses to CCR5 and SIVmac239 envelope glycoprotein.
    Otsubo Y; Yashiro S; Nozaki K; Matsuura K; Kiyonaga K; Mitsumata R; Takahashi Y; Masuyama M; Muneoka A; Takamune N; Shoji S; Misumi S
    Biochem Biophys Res Commun; 2014 Jan; 443(1):301-7. PubMed ID: 24309114
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The simian immunodeficiency virus transmembrane protein is poorly immunogenic in inactivated virus vaccine.
    Cranage MP; McBride BW; Rud EW
    Vaccine; 1995 Jul; 13(10):895-900. PubMed ID: 7483761
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine.
    Bahnemann HG
    Vaccine; 1990 Aug; 8(4):299-303. PubMed ID: 2204242
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine.
    Race E; Stein CA; Wigg MD; Baksh A; Addawe M; Frezza P; Oxford JS
    Vaccine; 1995 Nov; 13(16):1567-75. PubMed ID: 8578844
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies.
    Blackburn NK; Besselaar TG
    J Virol Methods; 1991 Aug; 33(3):367-74. PubMed ID: 1723736
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Combination of Paraformaldehyde and Glutaraldehyde Is a Potential Fixative for Mitochondria.
    Qin Y; Jiang W; Li A; Gao M; Liu H; Gao Y; Tian X; Gong G
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34068806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inactivation of adenovirus and simian virus 40 tumorigenicity in hamsters by vaccine processing methods.
    Truffelli GT; Timm EA; Beardmore WB; McLean IW
    Appl Microbiol; 1967 May; 15(3):516-27. PubMed ID: 4291954
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inactivation of viruses by aziridines.
    Brown F
    Vaccine; 2001 Nov; 20(3-4):322-7. PubMed ID: 11672893
    [No Abstract]   [Full Text] [Related]  

  • 76. PFA is superior to glyoxal in preserving oocyte, embryo, and stem cell proteins evidenced by super-resolution microscopical surveys of epitopes.
    Celikkan FT; Mungan C; Sucu M; Uysal F; Kahveci Hayme S; Hayme S; Kuscu N; Ozkavukcu S; Celik-Ozenci C; Can A
    J Assist Reprod Genet; 2020 Feb; 37(2):369-384. PubMed ID: 31930433
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Paraformaldehyde fixation and some characteristics of lens proteins as measured by Raman microspectroscopy.
    Schyns MW; Huizinga A; Vrensen GF; de Mul FF; Greve J
    Exp Eye Res; 1990 Mar; 50(3):331-3. PubMed ID: 2318277
    [No Abstract]   [Full Text] [Related]  

  • 78. Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins.
    Hulskotte EG; Dings ME; Norley SG; Osterhaus AD
    Vaccine; 1997 Dec; 15(17-18):1839-45. PubMed ID: 9413091
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
    Hu SL; Travis BM; Stallard V; Abrams K; Misher L; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1489-94. PubMed ID: 1466988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.